Agonist-independent activation of Src tyrosine kinase by a cholecystokinin-2 (CCK₂) receptor splice variant

Keyphrases

• Cholecystokinin 100%
• Receptor Splice Variants 100%
• Cholecystokinin-2 Receptor 100%
• Src Tyrosine Kinase 100%
• Gastrin-releasing Peptide Receptor (GRPr) 80%
• Src Kinase 60%
• CCK2 60%
• Pancreatic Cancer 40%
• Human Pancreatic Cancer 40%
• Splice Variants 40%
• Fold Increase 20%
• Kinase Activity 20%
• Colorectal Cancer 20%
• G Protein-coupled Receptor 20%
• Colon Cancer 20%
• Human Colorectal Cancer 20%
• Amino Acids 20%
• Receptor-interacting Protein Kinase 1 (RIPK1) 20%
• Aggressive Tumor 20%
• Co-expression 20%
• Nonmalignant 20%
• Third Intracellular Loop 20%
• Human Colon Cancer 20%
• Neoplastic Cells 20%
• In Vitro Kinase Assay 20%
• Increased Activity 20%
• Agonist Binding 20%
• HEK293 Cells 20%

Biochemistry, Genetics and Molecular Biology

• Agonist 100%
• Receptor Tyrosine Kinase 100%
• Cholecystokinin 100%
• Tyrosine Kinase 100%
• Phosphotransferase 50%
• Kinase 50%
• Gastrin 50%
• G Protein Coupled Receptor 12%
• Colon 12%
• Amino Acids 12%